
In Brief—CHANGE Act HR 4957/S 2387
Concentrating on High-Value Alzheimer’s Needs to Get to an End
The CHANGE Act outlines the difficulties of Alzheimer’s research and education. Clarifies the need for CMS to communicate the validated, evidence-based detection tools to clinicians under the already existing cognitive impairment detection benefit for Medicare beneficiaries in the annual wellness visit. Creates a new comprehensive continuum of care framework that brings together the many models already developed and tested for care for Alzheimer’s patients:
OUR DIGITAL PARTNERS






